• Something wrong with this record ?

Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study

RK. Sandhu, KK. Quadros, YY. Liu, M. Glikson, V. Kutyifa, P. Mabo, S. Hohnloser, G. O'Hara, L. VanErven, J. Neuzner, J. Kautzner, F. Gadler, X. Vinolas, U. Appl, SJ. Connolly, JS. Healey,

. 2018 ; 20 (11) : 1798-1803. [pub] 20181101

Language English Country England, Great Britain

Document type Journal Article, Randomized Controlled Trial

Aims: No standard practice exists with respect to anaesthesiologist-directed sedation (ADS) vs. sedation by proceduralist (PDS) for defibrillation threshold (DT) testing. We aimed to evaluate adverse events and safety outcomes with ADS vs. PDS for DT testing. Methods and results: A post hoc analysis of the Shockless Implant Evaluation (SIMPLE) study was performed among the 1242 patients who had DT testing (624 ADS and 618 PDS). We evaluated both intraoperative and in-hospital adverse composite events and two safety composite outcomes at 30-days of the main trial. Propensity score adjusted models were used to compute odds ratio (OR) and 95% confidence interval (CI) to evaluate the association between adverse and safety outcomes with method of sedation and independent predictors for use of ADS. Compared to PDS, patients who received ADS were younger (62 ± 12 years vs. 64 ± 12 years, P = 0.01), had lower ejection fraction (left ventricular ejection fraction 0.31 ± 13 vs. 0.33 ± 13, P = 0.03), were more likely to receive inhalational anaesthesia, propofol, or narcotics (P < 0.001, respectively) and receive an arterial line (43% vs. 8%, P = <0.0001). Independent predictors for ADS sedation were presence of coronary artery disease (OR 1.69, 95% CI 1.0-2.72; P = 0.03) and hypertrophic cardiomyopathy (OR 2.64, 95% CI 1.19-5.85; P = 0.02). Anaesthesiologist directed sedation had higher intraoperative adverse events (2.2% vs. 0.5%; OR 4.47, 95% CI 1.25-16.0; P = 0.02) and higher primary safety outcomes at 30 days (8.2% vs. 4.9%; OR 1.72 95% CI 1.06-2.80; P = 0.03) and no difference in other outcomes compared to PDS. Conclusion: Proceduralist-directed sedation is safe, however, this could be result of selection bias. Further research is needed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028394
003      
CZ-PrNML
005      
20190815105319.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euy114 $2 doi
035    __
$a (PubMed)29878102
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sandhu, Roopinder K $u Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street, 2C2 WMC Edmonton, AB, Canada.
245    10
$a Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study / $c RK. Sandhu, KK. Quadros, YY. Liu, M. Glikson, V. Kutyifa, P. Mabo, S. Hohnloser, G. O'Hara, L. VanErven, J. Neuzner, J. Kautzner, F. Gadler, X. Vinolas, U. Appl, SJ. Connolly, JS. Healey,
520    9_
$a Aims: No standard practice exists with respect to anaesthesiologist-directed sedation (ADS) vs. sedation by proceduralist (PDS) for defibrillation threshold (DT) testing. We aimed to evaluate adverse events and safety outcomes with ADS vs. PDS for DT testing. Methods and results: A post hoc analysis of the Shockless Implant Evaluation (SIMPLE) study was performed among the 1242 patients who had DT testing (624 ADS and 618 PDS). We evaluated both intraoperative and in-hospital adverse composite events and two safety composite outcomes at 30-days of the main trial. Propensity score adjusted models were used to compute odds ratio (OR) and 95% confidence interval (CI) to evaluate the association between adverse and safety outcomes with method of sedation and independent predictors for use of ADS. Compared to PDS, patients who received ADS were younger (62 ± 12 years vs. 64 ± 12 years, P = 0.01), had lower ejection fraction (left ventricular ejection fraction 0.31 ± 13 vs. 0.33 ± 13, P = 0.03), were more likely to receive inhalational anaesthesia, propofol, or narcotics (P < 0.001, respectively) and receive an arterial line (43% vs. 8%, P = <0.0001). Independent predictors for ADS sedation were presence of coronary artery disease (OR 1.69, 95% CI 1.0-2.72; P = 0.03) and hypertrophic cardiomyopathy (OR 2.64, 95% CI 1.19-5.85; P = 0.02). Anaesthesiologist directed sedation had higher intraoperative adverse events (2.2% vs. 0.5%; OR 4.47, 95% CI 1.25-16.0; P = 0.02) and higher primary safety outcomes at 30 days (8.2% vs. 4.9%; OR 1.72 95% CI 1.06-2.80; P = 0.03) and no difference in other outcomes compared to PDS. Conclusion: Proceduralist-directed sedation is safe, however, this could be result of selection bias. Further research is needed.
650    _2
$a senioři $7 D000368
650    12
$a analgosedace $x škodlivé účinky $x metody $7 D016292
650    _2
$a náhlá srdeční smrt $x etiologie $x prevence a kontrola $7 D016757
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a hypnotika a sedativa $x aplikace a dávkování $x škodlivé účinky $7 D006993
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a výsledky a postupy - zhodnocení (zdravotní péče) $7 D010043
650    12
$a pooperační komplikace $x diagnóza $x epidemiologie $x etiologie $7 D011183
650    12
$a implantace protézy $x škodlivé účinky $x přístrojové vybavení $x metody $7 D019919
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a fibrilace komor $x terapie $7 D014693
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Quadros, Kenneth K $u Mazankowski Alberta Heart Institute, University of Alberta, 8440-112 Street, 2C2 WMC Edmonton, AB, Canada.
700    1_
$a Liu, Yan Yun $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Glikson, Michael $u Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel.
700    1_
$a Kutyifa, Valentina $u Hungary-Semmelweis Univ Sch Med, Budapest, Hungary.
700    1_
$a Mabo, Phillipe $u Centre Hospitalier Universitaire, Rennes, France.
700    1_
$a Hohnloser, Stefan $u JW Goethe University, Frankfurt, Germany.
700    1_
$a O'Hara, Gilles $u Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada.
700    1_
$a VanErven, Liselot $u Leiden University Medical Center, Leiden, the Netherlands.
700    1_
$a Neuzner, Jorg $u Klinikum Kassel, Kassel, Germany.
700    1_
$a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Gadler, Frederik $u Karolinska Institute, Stockholm, Sweden.
700    1_
$a Vinolas, Xavier $u Hospital de Santa Creu i Sant Pau, Barcelona, Spain.
700    1_
$a Appl, Ursula $u Boston Scientific, Minneapolis, MN, USA. Boston Scientific, Brussels, Belgium.
700    1_
$a Connolly, Stuart J $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
700    1_
$a Healey, Jeff S $u Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
773    0_
$w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 20, č. 11 (2018), s. 1798-1803
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29878102 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190815105547 $b ABA008
999    __
$a ok $b bmc $g 1433543 $s 1066854
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 20 $c 11 $d 1798-1803 $e 20181101 $i 1532-2092 $m Europace $n Europace $x MED00149837
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...